Transdermal administration of apomorphine
Patent 5939094 Issued on August 17, 1999. Estimated Expiration Date: 
October 8, 2016. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
October 8, 2016. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesInventorsAssigneeApplicationNo. 727189 filed on 10/08/1996US Classes:424/448, Pressure sensitive adhesive means424/449Transdermal or percutaneousExaminersPrimary: Brouillette, GabrielleAttorney, Agent or FirmInternational ClassA61F 013/02AbstractDosage forms for the transdermal administration of apomorphine are described. The dosage forms are water-soluble gel compositions that contain apomorphine, optionally together with a permeation enhancer, or transdermal patches.Other References
| |
